Jiangsu Hengrui reported CNY40.96B in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
Kangmei Pharma CNY 1.23B 48.16M Mar/2026
Sh Fosun Pharma CNY 13.1B 1.63B Dec/2025
Sh Pharmaceutical CNY 36.73B 2.36B Sep/2025
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Wuxi Apptec CNY 35.91B 773.93M Mar/2026
Zz Pientze Pharmaceu CNY 1.96B 186.63M Mar/2026